tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

HK:9926

Akeso’s Immunotherapy Drugs Join China’s Reimbursement List
Company AnnouncementsAkeso’s Immunotherapy Drugs Join China’s Reimbursement List
25d ago
9926
Akeso, Inc. Raises HK$1.924 Billion Through Share Placement
PremiumCompany Announcements
Akeso, Inc. Raises HK$1.924 Billion Through Share Placement
2M ago
9926
Akeso, Inc. Aims to Raise HK$1.94 Billion in Share Placement
PremiumCompany Announcements
Akeso, Inc. Aims to Raise HK$1.94 Billion in Share Placement
2M ago
9926
Akeso, Inc.’s New Cholesterol Drug Approved in China
PremiumCompany Announcements
Akeso, Inc.’s New Cholesterol Drug Approved in China
3M ago
9926
Akeso’s Breakthrough Drug Wins Approval for Gastric Cancer
PremiumCompany Announcements
Akeso’s Breakthrough Drug Wins Approval for Gastric Cancer
3M ago
9926
Akeso’s Ivonescimab Shows Promise in NSCLC Treatment
PremiumCompany AnnouncementsAkeso’s Ivonescimab Shows Promise in NSCLC Treatment
4M ago
9926
Akeso, Inc. Reports Mixed Mid-Year Financial Results
Premium
Company Announcements
Akeso, Inc. Reports Mixed Mid-Year Financial Results
4M ago
9926
Akeso, Inc. Schedules Key Financial Review Meeting
Premium
Company Announcements
Akeso, Inc. Schedules Key Financial Review Meeting
4M ago
9926
Akeso’s Innovative Cancer Drug Advancing Globally
PremiumCompany Announcements
Akeso’s Innovative Cancer Drug Advancing Globally
4M ago
9926
Akeso’s Cancer Drug Ivonescimab Shows Promising Trial Results
PremiumCompany Announcements
Akeso’s Cancer Drug Ivonescimab Shows Promising Trial Results
5M ago
9926
Akeso, Inc. Appoints New CFO, Dr. Bing Wang
PremiumCompany Announcements
Akeso, Inc. Appoints New CFO, Dr. Bing Wang
5M ago
9926
Akeso, Inc. Reveals Board of Directors Structure
PremiumCompany Announcements
Akeso, Inc. Reveals Board of Directors Structure
6M ago
9926
Akeso, Inc. Shareholders Approve Key Resolutions
PremiumCompany AnnouncementsAkeso, Inc. Shareholders Approve Key Resolutions
6M ago
9926
Akeso, Inc. Announces Board Reshuffle
Premium
Company Announcements
Akeso, Inc. Announces Board Reshuffle
6M ago
9926
Akeso, Inc. Schedules Annual General Meeting
Premium
Company Announcements
Akeso, Inc. Schedules Annual General Meeting
7M ago
9926
Akeso, Inc. Proposes Share Scheme Overhaul
PremiumCompany Announcements
Akeso, Inc. Proposes Share Scheme Overhaul
7M ago
9926
Akeso Broadens Ivonescimab Agreement With Summit
PremiumCompany Announcements
Akeso Broadens Ivonescimab Agreement With Summit
7M ago
9926
Akeso’s Ivonescimab Outperforms in Clinical Trial
PremiumCompany Announcements
Akeso’s Ivonescimab Outperforms in Clinical Trial
7M ago
9926
Akeso, Inc.’s New Cancer Drug Wins China Approval
PremiumCompany Announcements
Akeso, Inc.’s New Cancer Drug Wins China Approval
7M ago
9926

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >